Viropharma Biologics competitive analysis

Latest publications and patents of Viropharma Biologics New

Explore the latest publications and patents granted to Viropharma Biologics, showcasing their recent innovations and technological advancements.

Last updated on: Sep 28, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Viropharma Biologics

Dec 29, 2021Corticosteroid CompositionsRevoked
Sep 22, 2021Methods Of Treatment For Esophageal InflammationRevoked
Jan 1, 2020Compositions For The Treatment Of Gastrointestinal InflammationRevoked
Jun 28, 2017C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor DeficencyRevoked

Explore Viropharma Biologics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Dec 29, 2021Corticosteroid Compositions1
Sep 22, 2021Methods Of Treatment For Esophageal Inflammation1
Jan 1, 2020Compositions For The Treatment Of Gastrointestinal Inflammation2
Jun 28, 2017C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency2

Latest PTAB cases involving Viropharma Biologics

Discover the latest PTAB cases involving Viropharma Biologics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Viropharma Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
VIROPHARMA BIOLOGICS - 6 - - Non-Active
AECHTER33 - - - Highly Aggressive
CSL BEHRING394 - Balanced
DR FALK PHARMA1026 - Highly Aggressive